Wealth Enhancement Trust Services
ROIV icon

Wealth Enhancement Trust Services’s Roivant Sciences ROIV Stock Holding History

Wealth Enhancement Trust Services’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-21
Closed -$743 – 1365
2026
Q2 		$743 Buy
+21
New +$621 ﹤0.01% 1180

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Wealth Enhancement Trust Services's ROIV Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of Roivant Sciences (ROIV) in Q3 2026, closing a stake of 21 shares — an estimated $743 sold.

Wealth Enhancement Trust Services first reported a position in ROIV in Q2 2026 and held it in 1 quarter. The position peaked at $743 in Q2 2026. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining Roivant Sciences position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 21 Roivant Sciences shares in Q3 2026, an estimated $743.
  • Wealth Enhancement Trust Services first reported a position in Roivant Sciences in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Trust Services's Roivant Sciences position peaked at $743 in Q2 2026.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.